Anthony Prentice

Anthony Prentice (senior executive) discloses dealings in GeneDx Holdings Corp. to SEC (Form 4). The record holds 8 filings, for trades running from 25 October 2021 to 25 July 2022.

Sales make up the whole of the open-market record (2 sales, €8,662). Other entries cover 1 share grant and 5 option exercises.

The record was last updated on 22 May 2023 with an option exercise in GeneDx Holdings Corp. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.